<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d577" origId="Indomethacin"><sentence id="DrugDDI.d577.s0" origId="s0" text="In normal volunteers receiving indomethacin, the administration of diflunisal decreased the renal clearance and significantly increased the plasma levels of indomethacin."><entity charOffset="31-43" id="DrugDDI.d577.s0.e0" origId="s0.p2" text="indomethacin" type="drug"/><entity charOffset="67-77" id="DrugDDI.d577.s0.e1" origId="s0.p4" text="diflunisal" type="drug"/><entity charOffset="157-169" id="DrugDDI.d577.s0.e2" origId="s0.p11" text="indomethacin" type="drug"/><pair e1="DrugDDI.d577.s0.e0" e2="DrugDDI.d577.s0.e1" id="DrugDDI.d577.s0.p0" interaction="false"/><pair e1="DrugDDI.d577.s0.e0" e2="DrugDDI.d577.s0.e2" id="DrugDDI.d577.s0.p1" interaction="false"/><pair e1="DrugDDI.d577.s0.e1" e2="DrugDDI.d577.s0.e2" id="DrugDDI.d577.s0.p2" interaction="true"/></sentence><sentence id="DrugDDI.d577.s1" origId="s1" text="In some patients, combined use of INDOCIN and diflunisal has been associated with fatal gastrointestinal hemorrhage."><entity charOffset="34-41" id="DrugDDI.d577.s1.e0" origId="s1.p14" text="INDOCIN" type="drug"/><entity charOffset="46-56" id="DrugDDI.d577.s1.e1" origId="s1.p16" text="diflunisal" type="drug"/><pair e1="DrugDDI.d577.s1.e0" e2="DrugDDI.d577.s1.e1" id="DrugDDI.d577.s1.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s2" origId="s2" text="Therefore, diflunisal and INDOCIN should not be used concomitantly."><entity charOffset="11-21" id="DrugDDI.d577.s2.e0" origId="s2.p22" text="diflunisal" type="drug"/><entity charOffset="26-33" id="DrugDDI.d577.s2.e1" origId="s2.p24" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s2.e0" e2="DrugDDI.d577.s2.e1" id="DrugDDI.d577.s2.p0" interaction="true"/><negationtags>Therefore, diflunisal and INDOCIN should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be used concomitantly&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d577.s3" origId="s3" text="In a study in normal volunteers, it was found that chronic concurrent administration of 3.6 g of aspirin per day decreases indomethacin blood levels approximately 20%."><entity charOffset="97-104" id="DrugDDI.d577.s3.e0" origId="s3.p37" text="aspirin" type="drug"/><entity charOffset="123-135" id="DrugDDI.d577.s3.e1" origId="s3.p40" text="indomethacin" type="drug"/><pair e1="DrugDDI.d577.s3.e0" e2="DrugDDI.d577.s3.e1" id="DrugDDI.d577.s3.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s4" origId="s4" text="The concomitant use of INDOCIN with other NSAIDs is not recommended due to the increased possibility of gastrointestinal toxicity, with little or no increase in efficacy."><entity charOffset="23-30" id="DrugDDI.d577.s4.e0" origId="s4.p42" text="INDOCIN" type="drug"/><entity charOffset="42-48" id="DrugDDI.d577.s4.e1" origId="s4.p43" text="NSAIDs" type="drug"/><pair e1="DrugDDI.d577.s4.e0" e2="DrugDDI.d577.s4.e1" id="DrugDDI.d577.s4.p0" interaction="true"/><negationtags>The concomitant use of INDOCIN with other NSAIDs is &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; recommended due to the increased possibility of gastrointestinal toxicity&lt;/xcope&gt;, with little or &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; increase in efficacy&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d577.s5" origId="s5" text="Clinical studies have shown that INDOCIN does not influence the hypoprothrombinemia produced by anticoagulants."><entity charOffset="33-40" id="DrugDDI.d577.s5.e0" origId="s5.p56" text="INDOCIN" type="drug"/><entity charOffset="96-110" id="DrugDDI.d577.s5.e1" origId="s5.p62" text="anticoagulants" type="drug"/><pair e1="DrugDDI.d577.s5.e0" e2="DrugDDI.d577.s5.e1" id="DrugDDI.d577.s5.p0" interaction="false"/><negationtags>Clinical studies have shown that INDOCIN does &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; influence the hypoprothrombinemia produced by anticoagulants&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d577.s6" origId="s6" text="However, when any additional drug, including INDOCIN, is added to the treatment of patients on anticoagulant therapy, the patients should be observed for alterations of the prothrombin time."><entity charOffset="29-33" id="DrugDDI.d577.s6.e0" origId="s6.p65" text="drug" type="drug"/><entity charOffset="45-52" id="DrugDDI.d577.s6.e1" origId="s6.p67" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s6.e0" e2="DrugDDI.d577.s6.e1" id="DrugDDI.d577.s6.p0" interaction="false"/></sentence><sentence id="DrugDDI.d577.s7" origId="s7" text="In post-marketing experience, bleeding has been reported in patients on concomitant treatment with anticoagulants and INDOCIN."><entity charOffset="99-113" id="DrugDDI.d577.s7.e0" origId="s7.p86" text="anticoagulants" type="drug"/><entity charOffset="118-125" id="DrugDDI.d577.s7.e1" origId="s7.p88" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s7.e0" e2="DrugDDI.d577.s7.e1" id="DrugDDI.d577.s7.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s8" origId="s8" text="Caution should be exercised when INDOCIN and anticoagulants are administered concomitantly."><entity charOffset="33-40" id="DrugDDI.d577.s8.e0" origId="s8.p94" text="INDOCIN" type="drug"/><entity charOffset="45-59" id="DrugDDI.d577.s8.e1" origId="s8.p96" text="anticoagulants" type="drug"/><pair e1="DrugDDI.d577.s8.e0" e2="DrugDDI.d577.s8.e1" id="DrugDDI.d577.s8.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s9" origId="s9" text="When INDOCIN is given to patients receiving probenecid, the plasma levels of indomethacin are likely to be increased."><entity charOffset="5-12" id="DrugDDI.d577.s9.e0" origId="s9.p101" text="INDOCIN" type="drug"/><entity charOffset="44-54" id="DrugDDI.d577.s9.e1" origId="s9.p106" text="probenecid" type="drug"/><entity charOffset="77-89" id="DrugDDI.d577.s9.e2" origId="s9.p108" text="indomethacin" type="drug"/><pair e1="DrugDDI.d577.s9.e0" e2="DrugDDI.d577.s9.e1" id="DrugDDI.d577.s9.p0" interaction="true"/><pair e1="DrugDDI.d577.s9.e0" e2="DrugDDI.d577.s9.e2" id="DrugDDI.d577.s9.p1" interaction="false"/><pair e1="DrugDDI.d577.s9.e1" e2="DrugDDI.d577.s9.e2" id="DrugDDI.d577.s9.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s10" origId="s10" text="Therefore, a lower total daily dosage of INDOCIN may produce a satisfactory therapeutic effect."><entity charOffset="41-48" id="DrugDDI.d577.s10.e0" origId="s10.p115" text="INDOCIN" type="drug"/></sentence><sentence id="DrugDDI.d577.s11" origId="s11" text="When increases in the dose of INDOCIN are made, they should be made carefully and in small increments."><entity charOffset="30-37" id="DrugDDI.d577.s11.e0" origId="s11.p122" text="INDOCIN" type="drug"/></sentence><sentence id="DrugDDI.d577.s12" origId="s12" text="Caution should be used if INDOCIN is administered simultaneously with methotrexate."><entity charOffset="26-33" id="DrugDDI.d577.s12.e0" origId="s12.p137" text="INDOCIN" type="drug"/><entity charOffset="70-82" id="DrugDDI.d577.s12.e1" origId="s12.p141" text="methotrexate" type="drug"/><pair e1="DrugDDI.d577.s12.e0" e2="DrugDDI.d577.s12.e1" id="DrugDDI.d577.s12.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s13" origId="s13" text="INDOCIN has been reported to decrease the tubular secretion of methotrexate and to potentiate its toxicity."><entity charOffset="0-7" id="DrugDDI.d577.s13.e0" origId="s13.p142" text="INDOCIN" type="drug"/><entity charOffset="63-75" id="DrugDDI.d577.s13.e1" origId="s13.p149" text="methotrexate" type="drug"/><pair e1="DrugDDI.d577.s13.e0" e2="DrugDDI.d577.s13.e1" id="DrugDDI.d577.s13.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s14" origId="s14" text="Administration of non-steroidal anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin."><entity charOffset="18-55" id="DrugDDI.d577.s14.e0" origId="s14.p155" text="non-steroidal anti-inflammatory drugs" type="drug"/><entity charOffset="75-87" id="DrugDDI.d577.s14.e1" origId="s14.p156" text="cyclosporine" type="drug"/><entity charOffset="204-216" id="DrugDDI.d577.s14.e2" origId="s14.p164" text="prostacyclin" type="drug"/><pair e1="DrugDDI.d577.s14.e0" e2="DrugDDI.d577.s14.e1" id="DrugDDI.d577.s14.p0" interaction="true"/><pair e1="DrugDDI.d577.s14.e0" e2="DrugDDI.d577.s14.e2" id="DrugDDI.d577.s14.p1" interaction="false"/><pair e1="DrugDDI.d577.s14.e1" e2="DrugDDI.d577.s14.e2" id="DrugDDI.d577.s14.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s15" origId="s15" text="NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored."><entity charOffset="0-6" id="DrugDDI.d577.s15.e0" origId="s15.p165" text="NSAIDs" type="drug"/><entity charOffset="54-66" id="DrugDDI.d577.s15.e1" origId="s15.p172" text="cyclosporine" type="drug"/><pair e1="DrugDDI.d577.s15.e0" e2="DrugDDI.d577.s15.e1" id="DrugDDI.d577.s15.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s16" origId="s16" text="Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations."><entity charOffset="81-88" id="DrugDDI.d577.s16.e0" origId="s16.p182" text="lithium" type="drug"/><entity charOffset="112-119" id="DrugDDI.d577.s16.e1" origId="s16.p185" text="lithium" type="drug"/><entity charOffset="199-206" id="DrugDDI.d577.s16.e2" origId="s16.p189" text="lithium" type="drug"/><pair e1="DrugDDI.d577.s16.e0" e2="DrugDDI.d577.s16.e1" id="DrugDDI.d577.s16.p0" interaction="false"/><pair e1="DrugDDI.d577.s16.e0" e2="DrugDDI.d577.s16.e2" id="DrugDDI.d577.s16.p1" interaction="false"/><pair e1="DrugDDI.d577.s16.e1" e2="DrugDDI.d577.s16.e2" id="DrugDDI.d577.s16.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s17" origId="s17" text="This effect has been attributed to inhibition of prostaglandin synthesis."><entity charOffset="49-62" id="DrugDDI.d577.s17.e0" origId="s17.p195" text="prostaglandin" type="drug"/></sentence><sentence id="DrugDDI.d577.s18" origId="s18" text="As a consequence, when INDOCIN and lithium are given concomitantly, the patient should be carefully observed for signs of lithium toxicity."><entity charOffset="23-30" id="DrugDDI.d577.s18.e0" origId="s18.p198" text="INDOCIN" type="drug"/><entity charOffset="35-42" id="DrugDDI.d577.s18.e1" origId="s18.p200" text="lithium" type="drug"/><pair e1="DrugDDI.d577.s18.e0" e2="DrugDDI.d577.s18.e1" id="DrugDDI.d577.s18.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s19" origId="s19" text="(Read circulars for lithium preparations before use of such concomitant therapy.)"><entity charOffset="20-39" id="DrugDDI.d577.s19.e0" origId="s19.p213" text="lithium preparation" type="drug"/></sentence><sentence id="DrugDDI.d577.s20" origId="s20" text="In addition, the frequency of monitoring serum lithium concentration should be increased at the outset of such combination drug treatment."><entity charOffset="47-54" id="DrugDDI.d577.s20.e0" origId="s20.p219" text="lithium" type="drug"/><entity charOffset="123-127" id="DrugDDI.d577.s20.e1" origId="s20.p224" text="drug" type="drug"/><pair e1="DrugDDI.d577.s20.e0" e2="DrugDDI.d577.s20.e1" id="DrugDDI.d577.s20.p0" interaction="false"/></sentence><sentence id="DrugDDI.d577.s21" origId="s21" text="INDOCIN given concomitantly with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin."><entity charOffset="0-7" id="DrugDDI.d577.s21.e0" origId="s21.p225" text="INDOCIN" type="drug"/><entity charOffset="33-40" id="DrugDDI.d577.s21.e1" origId="s21.p228" text="digoxin" type="drug"/><entity charOffset="124-131" id="DrugDDI.d577.s21.e2" origId="s21.p238" text="digoxin" type="drug"/><pair e1="DrugDDI.d577.s21.e0" e2="DrugDDI.d577.s21.e1" id="DrugDDI.d577.s21.p0" interaction="true"/><pair e1="DrugDDI.d577.s21.e0" e2="DrugDDI.d577.s21.e2" id="DrugDDI.d577.s21.p1" interaction="false"/><pair e1="DrugDDI.d577.s21.e1" e2="DrugDDI.d577.s21.e2" id="DrugDDI.d577.s21.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s22" origId="s22" text="Therefore, when INDOCIN and digoxin are used concomitantly, serum digoxin levels should be closely monitored."><entity charOffset="16-23" id="DrugDDI.d577.s22.e0" origId="s22.p241" text="INDOCIN" type="drug"/><entity charOffset="28-35" id="DrugDDI.d577.s22.e1" origId="s22.p243" text="digoxin" type="drug"/><pair e1="DrugDDI.d577.s22.e0" e2="DrugDDI.d577.s22.e1" id="DrugDDI.d577.s22.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s23" origId="s23" text="In some patients, the administration of INDOCIN can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing, and thiazide diuretics."><entity charOffset="40-47" id="DrugDDI.d577.s23.e0" origId="s23.p254" text="INDOCIN" type="drug"/><entity charOffset="63-71" id="DrugDDI.d577.s23.e1" origId="s23.p257" text="diuretic" type="drug"/><entity charOffset="90-106" id="DrugDDI.d577.s23.e2" origId="s23.p259" text="antihypertensive" type="drug"/><entity charOffset="124-133" id="DrugDDI.d577.s23.e3" origId="s23.p261" text="potassium" type="drug"/><entity charOffset="147-165" id="DrugDDI.d577.s23.e4" origId="s23.p263" text="thiazide diuretics" type="drug"/><pair e1="DrugDDI.d577.s23.e0" e2="DrugDDI.d577.s23.e1" id="DrugDDI.d577.s23.p0" interaction="false"/><pair e1="DrugDDI.d577.s23.e0" e2="DrugDDI.d577.s23.e2" id="DrugDDI.d577.s23.p1" interaction="false"/><pair e1="DrugDDI.d577.s23.e0" e2="DrugDDI.d577.s23.e3" id="DrugDDI.d577.s23.p2" interaction="false"/><pair e1="DrugDDI.d577.s23.e0" e2="DrugDDI.d577.s23.e4" id="DrugDDI.d577.s23.p3" interaction="true"/><pair e1="DrugDDI.d577.s23.e1" e2="DrugDDI.d577.s23.e2" id="DrugDDI.d577.s23.p4" interaction="false"/><pair e1="DrugDDI.d577.s23.e1" e2="DrugDDI.d577.s23.e3" id="DrugDDI.d577.s23.p5" interaction="false"/><pair e1="DrugDDI.d577.s23.e1" e2="DrugDDI.d577.s23.e4" id="DrugDDI.d577.s23.p6" interaction="false"/><pair e1="DrugDDI.d577.s23.e2" e2="DrugDDI.d577.s23.e3" id="DrugDDI.d577.s23.p7" interaction="false"/><pair e1="DrugDDI.d577.s23.e2" e2="DrugDDI.d577.s23.e4" id="DrugDDI.d577.s23.p8" interaction="false"/><pair e1="DrugDDI.d577.s23.e3" e2="DrugDDI.d577.s23.e4" id="DrugDDI.d577.s23.p9" interaction="false"/></sentence><sentence id="DrugDDI.d577.s24" origId="s24" text="Therefore, when INDOCIN and INDOCIN."><entity charOffset="16-23" id="DrugDDI.d577.s24.e0" origId="s24.p266" text="INDOCIN" type="drug"/><entity charOffset="28-35" id="DrugDDI.d577.s24.e1" origId="s24.p268" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s24.e0" e2="DrugDDI.d577.s24.e1" id="DrugDDI.d577.s24.p0" interaction="false"/></sentence><sentence id="DrugDDI.d577.s25" origId="s25" text="(Indomethacin) diuretics are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."><entity charOffset="1-13" id="DrugDDI.d577.s25.e0" origId="s25.p270" text="Indomethacin" type="drug"/><entity charOffset="15-24" id="DrugDDI.d577.s25.e1" origId="s25.p272" text="diuretics" type="drug"/><entity charOffset="130-138" id="DrugDDI.d577.s25.e2" origId="s25.p283" text="diuretic" type="drug"/><pair e1="DrugDDI.d577.s25.e0" e2="DrugDDI.d577.s25.e1" id="DrugDDI.d577.s25.p0" interaction="false"/><pair e1="DrugDDI.d577.s25.e0" e2="DrugDDI.d577.s25.e2" id="DrugDDI.d577.s25.p1" interaction="false"/><pair e1="DrugDDI.d577.s25.e1" e2="DrugDDI.d577.s25.e2" id="DrugDDI.d577.s25.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s26" origId="s26" text="INDOCIN reduces basal plasma renin activity (PRA), as well as those elevations of PRA induced by furosemide administration, or salt or volume depletion."><entity charOffset="0-7" id="DrugDDI.d577.s26.e0" origId="s26.p286" text="INDOCIN" type="drug"/><entity charOffset="97-108" id="DrugDDI.d577.s26.e1" origId="s26.p297" text="furosemide" type="drug"/><entity charOffset="127-131" id="DrugDDI.d577.s26.e2" origId="s26.p299" text="salt" type="drug"/><pair e1="DrugDDI.d577.s26.e0" e2="DrugDDI.d577.s26.e1" id="DrugDDI.d577.s26.p0" interaction="false"/><pair e1="DrugDDI.d577.s26.e0" e2="DrugDDI.d577.s26.e2" id="DrugDDI.d577.s26.p1" interaction="false"/><pair e1="DrugDDI.d577.s26.e1" e2="DrugDDI.d577.s26.e2" id="DrugDDI.d577.s26.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s27" origId="s27" text="These facts should be considered when evaluating plasma renin activity in hypertensive patients."/><sentence id="DrugDDI.d577.s28" origId="s28" text="It has been reported that the addition of triamterene to a maintenance schedule of INDOCIN resulted in reversible acute renal failure in two of four healthy volunteers."><entity charOffset="42-53" id="DrugDDI.d577.s28.e0" origId="s28.p314" text="triamterene" type="drug"/><entity charOffset="83-90" id="DrugDDI.d577.s28.e1" origId="s28.p316" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s28.e0" e2="DrugDDI.d577.s28.e1" id="DrugDDI.d577.s28.p0" interaction="true"/><negationtags>It has been reported that the addition of triamterene to a maintenance schedule of INDOCIN resulted in reversible acute renal &lt;xcope&gt;&lt;cue&gt;failure&lt;/cue&gt; in two of four healthy volunteers&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d577.s29" origId="s29" text="INDOCIN and triamterene should not be administered together."><entity charOffset="0-7" id="DrugDDI.d577.s29.e0" origId="s29.p321" text="INDOCIN" type="drug"/><entity charOffset="12-23" id="DrugDDI.d577.s29.e1" origId="s29.p323" text="triamterene" type="drug"/><pair e1="DrugDDI.d577.s29.e0" e2="DrugDDI.d577.s29.e1" id="DrugDDI.d577.s29.p0" interaction="true"/><negationtags>INDOCIN and triamterene should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be administered together&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d577.s30" origId="s30" text="INDOCIN and potassium-sparing diuretics each may be associated with increased serum potassium levels."><entity charOffset="0-7" id="DrugDDI.d577.s30.e0" origId="s30.p329" text="INDOCIN" type="drug"/><entity charOffset="12-39" id="DrugDDI.d577.s30.e1" origId="s30.p331" text="potassium-sparing diuretics" type="drug"/><pair e1="DrugDDI.d577.s30.e0" e2="DrugDDI.d577.s30.e1" id="DrugDDI.d577.s30.p0" interaction="true"/></sentence><sentence id="DrugDDI.d577.s31" origId="s31" text="The potential effects of INDOCIN and potassium-sparing diuretics on potassium kinetics and renal function should be considered when these agents are administered concurrently."><entity charOffset="25-32" id="DrugDDI.d577.s31.e0" origId="s31.p338" text="INDOCIN" type="drug"/><entity charOffset="37-64" id="DrugDDI.d577.s31.e1" origId="s31.p340" text="potassium-sparing diuretics" type="drug"/><entity charOffset="68-77" id="DrugDDI.d577.s31.e2" origId="s31.p341" text="potassium" type="drug"/><pair e1="DrugDDI.d577.s31.e0" e2="DrugDDI.d577.s31.e1" id="DrugDDI.d577.s31.p0" interaction="true"/><pair e1="DrugDDI.d577.s31.e0" e2="DrugDDI.d577.s31.e2" id="DrugDDI.d577.s31.p1" interaction="false"/><pair e1="DrugDDI.d577.s31.e1" e2="DrugDDI.d577.s31.e2" id="DrugDDI.d577.s31.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s32" origId="s32" text="Most of the above effects concerning diuretics have been attributed, at least in part, to mechanisms involving inhibition of prostaglandin synthesis by INDOCIN."><entity charOffset="37-46" id="DrugDDI.d577.s32.e0" origId="s32.p355" text="diuretics" type="drug"/><entity charOffset="125-138" id="DrugDDI.d577.s32.e1" origId="s32.p365" text="prostaglandin" type="drug"/><entity charOffset="152-159" id="DrugDDI.d577.s32.e2" origId="s32.p366" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s32.e0" e2="DrugDDI.d577.s32.e1" id="DrugDDI.d577.s32.p0" interaction="false"/><pair e1="DrugDDI.d577.s32.e0" e2="DrugDDI.d577.s32.e2" id="DrugDDI.d577.s32.p1" interaction="false"/><pair e1="DrugDDI.d577.s32.e1" e2="DrugDDI.d577.s32.e2" id="DrugDDI.d577.s32.p2" interaction="false"/></sentence><sentence id="DrugDDI.d577.s33" origId="s33" text="Blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by non-steroidal antiinflammatory drugs including INDOCIN has been reported."><entity charOffset="16-32" id="DrugDDI.d577.s33.e0" origId="s33.p368" text="antihypertensive" type="drug"/><entity charOffset="43-75" id="DrugDDI.d577.s33.e1" origId="s33.p369" text="beta-adrenoceptor blocking agent" type="drug"/><entity charOffset="80-116" id="DrugDDI.d577.s33.e2" origId="s33.p370" text="non-steroidal antiinflammatory drugs" type="drug"/><entity charOffset="127-134" id="DrugDDI.d577.s33.e3" origId="s33.p372" text="INDOCIN" type="drug"/><pair e1="DrugDDI.d577.s33.e0" e2="DrugDDI.d577.s33.e1" id="DrugDDI.d577.s33.p0" interaction="false"/><pair e1="DrugDDI.d577.s33.e0" e2="DrugDDI.d577.s33.e2" id="DrugDDI.d577.s33.p1" interaction="false"/><pair e1="DrugDDI.d577.s33.e0" e2="DrugDDI.d577.s33.e3" id="DrugDDI.d577.s33.p2" interaction="false"/><pair e1="DrugDDI.d577.s33.e1" e2="DrugDDI.d577.s33.e2" id="DrugDDI.d577.s33.p3" interaction="true"/><pair e1="DrugDDI.d577.s33.e1" e2="DrugDDI.d577.s33.e3" id="DrugDDI.d577.s33.p4" interaction="false"/><pair e1="DrugDDI.d577.s33.e2" e2="DrugDDI.d577.s33.e3" id="DrugDDI.d577.s33.p5" interaction="false"/></sentence><sentence id="DrugDDI.d577.s34" origId="s34" text="Therefore, when using these blocking agents to treat hypertension, patients should be observed carefully in order to confirm that the desired therapeutic effect has been obtained."/><sentence id="DrugDDI.d577.s35" origId="s35" text="INDOCIN can reduce the antihypertensive effects of captopril and losartan."><entity charOffset="0-7" id="DrugDDI.d577.s35.e0" origId="s35.p393" text="INDOCIN" type="drug"/><entity charOffset="23-39" id="DrugDDI.d577.s35.e1" origId="s35.p396" text="antihypertensive" type="drug"/><entity charOffset="51-60" id="DrugDDI.d577.s35.e2" origId="s35.p397" text="captopril" type="drug"/><entity charOffset="65-73" id="DrugDDI.d577.s35.e3" origId="s35.p399" text="losartan" type="drug"/><pair e1="DrugDDI.d577.s35.e0" e2="DrugDDI.d577.s35.e1" id="DrugDDI.d577.s35.p0" interaction="false"/><pair e1="DrugDDI.d577.s35.e0" e2="DrugDDI.d577.s35.e2" id="DrugDDI.d577.s35.p1" interaction="true"/><pair e1="DrugDDI.d577.s35.e0" e2="DrugDDI.d577.s35.e3" id="DrugDDI.d577.s35.p2" interaction="false"/><pair e1="DrugDDI.d577.s35.e1" e2="DrugDDI.d577.s35.e2" id="DrugDDI.d577.s35.p3" interaction="false"/><pair e1="DrugDDI.d577.s35.e1" e2="DrugDDI.d577.s35.e3" id="DrugDDI.d577.s35.p4" interaction="false"/><pair e1="DrugDDI.d577.s35.e2" e2="DrugDDI.d577.s35.e3" id="DrugDDI.d577.s35.p5" interaction="false"/></sentence><sentence id="DrugDDI.d577.s36" origId="s36" text="False-negative results in the dexamethasone suppression test (DST) in patients being treated with INDOCIN have been reported."><entity charOffset="98-105" id="DrugDDI.d577.s36.e0" origId="s36.p408" text="INDOCIN" type="drug"/></sentence><sentence id="DrugDDI.d577.s37" origId="s37" text="Thus, results of the DST should be interpreted with caution in these patients."/></document>